Effect of omega-3 supplementation on cognitive function in patients with early-stage alzheimer's disease: a novel randomized controlled trial
Abstract
A progressive neurodegenerative condition connected with cognitive decline, Alzheimer's disease (AD) is also known as Alzheimer's disease. Although omega3 fatty acids have been proposed to have neuroprotective effects, their influence on early-stage AD remains underinvestigated. The impact of daily omega-3 supplementation on cognitive performance in adults with early-stage AD is assessed in this research. 45 individuals between the ages of 55 and 75, drawn from memory clinics and neurology departments using stratified random sampling, participated in a randomized controlled experiment. For six months, participants were randomly allocated to either a placebo group (n=22) or an omega3 supplementation group (n=23). At baseline and after intervention, cognitive performance was evaluated using the Montreal Cognitive Assessment (MoCA) and the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADASCog). Mood and daily activities Were assessed with the Geriatric Depression Scale (GDS) and Activities of Daily Living (ADL) scale. Mean MoCA score following treatment was 24.1 ± 2.2 in the omega3 group compared to 23.0 ± 2.4 in the placebo group (p=0.04). The ADASCog scores fell by 2.0 ± 0.7 points p=0.03 for the omega3 group versus 0.9 ± 0.8 points in the placebo group. Enhancements in GDS and ADL scores were seen in the supplementation group, However, differences were not statistically significant (p>0.05). Omega3 supplementation for six months showed a slight but statistically…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 45 participants or records.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.